Epigenetic Changes in Diabetes and Cardiovascular Risk

Area of Science:

• Cardiovascular Research
• Epigenetics
• Diabetology

Background:

• Cardiovascular complications are a major cause of death in diabetes mellitus.
• Previous high glucose exposure causes lasting gene expression changes in vasculopathies.
• Epigenetic mechanisms, particularly chromatin alterations, contribute to the biological memory of diabetic cardiovascular disease.

Purpose of the Study:

• To review epigenetic mechanisms of macrovascular disease in diabetes mellitus.
• To highlight chromatin changes in vascular cells associated with persistent gene expression in atherosclerosis.
• To discuss challenges in targeting epigenetic networks for diabetic cardiovascular disease treatment.

Main Methods:

• Review of current literature on epigenetic mechanisms in diabetic cardiovascular disease.
• Analysis of cell type-specific epigenetic roles in the diabetic vasculature.
• Discussion of challenges in pharmacological targeting of epigenetic networks.

Main Results:

• Persistent gene expression changes in endothelial, smooth muscle, and immune cells are linked to atherosclerosis in diabetes.
• Chromatin architectures sensitize the genome to cardiometabolic risk factors.
• Distinct epigenomes in various cell types contribute to atherosclerosis.

Conclusions:

• Epigenetic modifications play a crucial role in the development and persistence of diabetic cardiovascular complications.
• Understanding cell type-specific epigenetic roles is key for developing effective interventions.
• Targeting epigenetic networks presents a promising, yet challenging, therapeutic strategy for diabetic cardiovascular disease.